Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AvitaROCO:4735 -2.31%70 OCF Margin % is 15.11% as of Jun. 2026, which is 1% above its 10-year median of 14.89. GuruFocus rates ROCO:4735 with a GF Score™ of 70/100 and a GF Value™ of NT$33.44 (Modestly Overvalued). The stock has 11 warning signs investors should review. Among 813 Medical Devices & Instruments companies, Avita ranks better than 51.54% on this metric.
OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Avita's Cash Flow from Operations for the
three
months ended in Jun. 2026 was NT$41.3 Mil. Avita's Revenue for the
three
months ended in Jun. 2026 was NT$273.4 Mil. Therefore, Avita's OCF Margin % for the quarter that ended in Jun. 2026 was 15.11%.
The historical rank and industry rank for Avita's OCF Margin % or its related term are showing as below:
ROCO:4735'
s OCF Margin % Range Over the Past 10 Years
Min: 6.88 Med: 14.89 Max: 40.84
Current: 7.19
During the past 13 years, the highest OCF Margin % of Avita was 40.84%. The lowest was 6.88%. And the median was 14.89%.
ROCO:4735's OCF Margin % is ranked better than 51.54% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: 6.43
vs ROCO:4735: 7.19
The historical data trend for Avita's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4735 vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Avita's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avita OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avita's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Avita's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avita (ROCO:4735) has a OCF Margin % of 15.11% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Avita and its competitors. This is near median its historical median of 14.89. Over the past decade, Avita's OCF Margin % has ranged from 6.88 to 40.84. According to the industry distribution chart, Avita ranks #394 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 48.5%.
Is Avita's OCF Margin % too high?
Avita's current OCF Margin % of 15.11% is near median its 10-year median of 14.89. Over the past 10 years, this metric has ranged from a low of 6.88 to a high of 40.84. The Medical Devices & Instruments industry median OCF Margin % is 6.43. Avita's value of 15.11% is 135% above this industry median. Based on the distribution chart, Avita ranks #394 out of 813 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Avita has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avita's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Avita ranks #394 out of 813 companies for OCF Margin %. This puts Avita in the upper half of its industry. The industry median OCF Margin % is 6.43. Avita's value of 15.11% is 135% above this benchmark. Historically, Avita's own OCF Margin % has ranged from 6.88 to 40.84 over the past decade. While the company's 10-year median is 14.89 vs. the industry median of 6.43, Avita has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.43, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avita's current OCF Margin % of 15.11% is 135% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Avita and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avita's current OCF Margin % is 15.11%, which is near median its own 10-year median of 14.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avita stock overvalued right now?
Based on GuruFocus' analysis, Avita (ROCO:4735) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$33.44, compared to a current price of NT$38.00 — trading 13.6% above its estimated fair value. The current OCF Margin % is 15.11%, which is near median its 10-year median of 14.89 and 135% above the Medical Devices & Instruments industry median of 6.43. Avita's overall GF Score™ is 70/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Avita (ROCO:4735), the current OCF Margin % is 15.11% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avita (ROCO:4735) Overvalued in 2026?
Based on GuruFocus' analysis, Avita stock appears to be overvalued.
The current stock price of NT$38.00 is trading 13.6% above its estimated GF Value™ of NT$33.44.
GuruFocus considers Avita to be Modestly Overvalued.
Key valuation signals for ROCO:4735:
OCF Margin %: 15.11% (near median its 10-year median of 14.89)
GF Value™: NT$33.44 vs. price of NT$38.00 (13.6% above fair value)
Industry Position: 135% above the Medical Devices & Instruments median (#394 of 813)
No single metric tells the full story. See the ROCO:4735 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avita Corp is a manufacturer of point-of-care health products designed for clinical and personal use. The company provides body composition analyzers, blood pressure monitors, blood glucose monitors, digital thermometers, and nasal care devices. Its products include a thermometer, nasal aspirator, blood pressure monitor arm, and wrist.
70GF Score
Get the complete analysis for ROCO:4735
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4735 has been successfully added to your 
